Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Gynecologic Oncology
|
June 1, 1987
Prognostic implications of large volume residual disease in patients with advanced stage epithelial ovarian cancer
H H Gallion, J R van Nagell, E S Donaldson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1986
Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells
J M Zarling, M Shoyab, H Marquardt, et al.
Cancer
|
July 15, 1981
Biochemical markers in the plasma and tumors of patients with gynecologic malignancies
J R van Nagell, E S Donaldson, M B Hanson, et al.
American Journal of Obstetrics and Gynecology
|
April 15, 1983
Microinvasive carcinoma of the cervix
J R van Nagell, N Greenwell, D F Powell, et al.
Biochemistry
|
June 5, 1984
Estrogenicity of coumestrol in the mouse: fluorescence detection of interaction with estrogen receptors
K Nelson, E J Pavlik, J R van Nagell, et al.
Gynecologic Oncology
|
October 1, 1982
Sensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell line
E J Pavlik, J R van Nagell, M B Hanson, et al.
Cancer
|
April 15, 1985
The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer
M B Hanson, J R van Nagell, D E Powell, et al.
Cancer
|
July 15, 1985
Combined radiation therapy and extra-fascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer
H H Gallion, J R van Nagell, E S Donaldson, et al.
Annals of the New York Academy of Sciences
|
July 21, 1995
In vivo properties of oncostatin M
P M Wallace, J F Macmaster, J R Rillema, et al.
American Journal of Obstetrics and Gynecology
|
May 15, 1984
Immunohistochemical localization of tumor markers in epithelial ovarian cancer
S Casper, J R van Nagell, D F Powell, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Gynecologic Oncology
|
June 1, 1987
Prognostic implications of large volume residual disease in patients with advanced stage epithelial ovarian cancer
H H Gallion, J R van Nagell, E S Donaldson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1986
Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells
J M Zarling, M Shoyab, H Marquardt, et al.
Cancer
|
July 15, 1981
Biochemical markers in the plasma and tumors of patients with gynecologic malignancies
J R van Nagell, E S Donaldson, M B Hanson, et al.
American Journal of Obstetrics and Gynecology
|
April 15, 1983
Microinvasive carcinoma of the cervix
J R van Nagell, N Greenwell, D F Powell, et al.
Biochemistry
|
June 5, 1984
Estrogenicity of coumestrol in the mouse: fluorescence detection of interaction with estrogen receptors
K Nelson, E J Pavlik, J R van Nagell, et al.
Gynecologic Oncology
|
October 1, 1982
Sensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell line
E J Pavlik, J R van Nagell, M B Hanson, et al.
Cancer
|
April 15, 1985
The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer
M B Hanson, J R van Nagell, D E Powell, et al.
Cancer
|
July 15, 1985
Combined radiation therapy and extra-fascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer
H H Gallion, J R van Nagell, E S Donaldson, et al.
Annals of the New York Academy of Sciences
|
July 21, 1995
In vivo properties of oncostatin M
P M Wallace, J F Macmaster, J R Rillema, et al.
American Journal of Obstetrics and Gynecology
|
May 15, 1984
Immunohistochemical localization of tumor markers in epithelial ovarian cancer
S Casper, J R van Nagell, D F Powell, et al.
Page
of 4